English
In recent years, the fields of biopharmaceuticals and cell engineering have been developing by leaps and bounds. To meet the increasing demand for cell culture, researchers and manufacturers are constantly seeking more efficient culture tools. And the 10-layer cell factory is one of them. With its unique design and superior performance, it becomes the ideal choice for large-scale cell culture.
1. Wide range of applications:
The 10-layer cell factory is suitable for a wide range of biopharmaceutical and cell engineering applications, including but not limited to production laboratories, large research institutions, and pharmaceutical plants. Whether you are producing recombinant proteins, vaccines or cellular therapeutic products, it is able to meet your large-scale cell culture needs.
2. Efficient culture area:
Compared to the traditional monolayer culture method, the 10-layer cell factory has a larger culture area and is able to culture many times the number of cells at the same time. This efficient culture method greatly improves production efficiency and helps to speed up new drug development and production cycle.
3. Large capacity features:
The design of the 10-layer cell factory allows it to accommodate a large number of cells, thus meeting the needs of large-scale production. This is particularly important for the production of high-value biologics, which can effectively reduce production costs and increase product competitiveness.
4. Reduced production costs:
Manufacturers can produce more products in the same production cycle, thus realizing large-scale production and reducing production costs. In addition, it can also reduce the investment of equipment and manpower to further improve production efficiency and reduce costs.
As an efficient, high-capacity cell culture tool, the 10-layer cell factory plays an important role in the fields of biopharmaceuticals and cell engineering. Its wide range of applications, efficient culture area, large capacity, and reduced production costs make it an indispensable tool for manufacturers and research institutions.
The FAI climbed 5.9 percent year-on-year in the first 11 months of 2018, quickening from the 5.7-percent growth in Jan-Oct, the National Bureau of Statistics (NBS) said Friday in an online statement.
The key indicator of investment, dubbed a major growth driver, hit the bottom in August and has since started to rebound steadily.
In the face of emerging economic challenges home and abroad, China has stepped up efforts to stabilize investment, in particular rolling out measures to motivate private investors and channel funds into infrastructure.
Friday's data showed private investment, accounting for more than 60 percent of the total FAI, expanded by a brisk 8.7 percent.
NBS spokesperson Mao Shengyong said funds into weak economic links registered rapid increases as investment in environmental protection and agriculture jumped 42 percent and 12.5 percent respectively, much faster than the average.
In breakdown, investment in high-tech and equipment manufacturing remained vigorous with 16.1-percent and 11.6-percent increases respectively in the first 11 months. Infrastructure investment gained 3.7 percent, staying flat. Investment in property development rose 9.7 percent, also unchanged.